Growth Hormone Releasing Peptide is classified under the category of drugs called GH Secretagogues. Drugs in this category include Hexarelin, Ipamorelin, GHRP-6 and GHRP-2. The primary role of these peptides is the stimulation of the pituitary glands to continue releasing more growth hormones. GHRP-2 has a two-step approach of action – they lead to an increase in the release of growth hormones by increasing the rate of GHRH inducing signals, and they also suppress the actions of somatostatin.
Growth hormone releasing peptide is considered as a 1st Gen GHRP, and it is currently being used for two main applications: Growth Hormone release, and stimulating appetite. Individuals considering using this peptide for GH release, should also keep in mind that its use will result in appetite stimulation, and they should consider whether this is warranted.
If the individuals have appetite problems and regularly struggle to eat their meals, then this appetite stimulation may be beneficial. For individuals on contest diets, however, considering the use of this hormone may not be advisable until the contest is over and one is free to eat without any restrictions.
Listed below are some of the common benefits of the GHRP:
The growth hormone releasing peptide also comes with a myriad of side effects, though not always severe. They include the following:
It is recommended that the peptide should be administered on an empty stomach, and that no food should be consumed for at least up to 30 minutes following administration, if you wish to enable maximum release of the growth hormone.